WEBINAR: GFI #256 - Implications of the Next Round of FDA Compounding Guidance
| Overview / Abstract: |
Compounding with bulk chemicals (APIs) for animal patients has been in a regulatory void since November 2017 when FDA abruptly withdrew its compounding guidance and did not replace it. In November 2019, FDA released a draft of proposed guidance for Industry addressing how FDA intends to apply enforcement discretion to pharmacists and veterinarians using APIs to compound for animal patients. In that guidance, FDA identifies enforcement priorities and proposes various lists of APIs that may or may not be used to compound for patient-specific prescriptions or for veterinary office stock. Attendees will appreciate which APIs and compounding activities will not be tolerated by FDA and will likely result in regulatory action. |
|
Expiration |
Feb 21, 2023 |
|
Discipline(s) |
Pharmacy CPE |
|
Format |
Online, Webinar / Webcast / Video |
|
Cost |
$40 Pharmacist Member | $22 Technician Member | $5 Student Member | $10 - $50 Non-Member |
|
Credits / Hours |
1.0 |
|
Accreditation |
ACPE |
|
Presenters / Authors / Faculty |
Gigi Davidson, RPh, DICVP, FSVHP, FACVP |
|
Activity Specialities / Related Topics |
Veterinary "Small Animals", Veterinary "Large Animals", Government / Regulatory, Compounding of Medications |
|
Sponsors / Supporters / Grant Providers |
This program is made possible by an unrestricted grant from ACHC. |
|
Keywords / Search Terms |
American College of Veterinary Pharmacists, American College of Apothecaries, Compounding, Veterinarians, Veterinary, Pharmacist, Pharmacy Technician, Government / Regulatory,CE, Webinars |
|